COG-AALL06N1 Trial Clinical Trial Title Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Trial Status Closed to Enrollment Start Date April 16, 2007 Location Randall Children's Hospital at Legacy Emanuel Medical Center Trial Type Pediatric Cancer (Oncology) Specific Condition Neurocognitive Function (ALL) Description A Study of Neurocognitive Function in Children Treated for Acute Lymphoblastic Leukemia (ALL) Eligibility Criteria Patient must have been >1 year and <18 years of age at the time diagnosed as having ALL Patient must be enrolled on AALL0434 (Cohort #1 only) or AALL0232 (Cohort #1 and #2) and must have received either high dose methotrexate or escalating dose methotrexate during interim maintenance Eligibility time period is 8-24 months post completion of AALL0232 protocol treatment Notes https://clinicaltrials.gov/ct2/show/NCT00437060 Study status is: Completed: The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred). Principal Investigator Name Janice Olson, MD Contact Name Children's Cancer and Blood Disorders Program Phone (503) 276-9300 Last Updated: Wednesday, January 27, 2021 11:41:04 AM